GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 22, 2025 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
5T03 | P0AEY0 | Crystal structure of heparan sulfate 6-O-sulfotransferase with bound PAP and glucuronic acid containing hexasaccharide substrate | |
5T03 | A0MGZ7 | Crystal structure of heparan sulfate 6-O-sulfotransferase with bound PAP and glucuronic acid containing hexasaccharide substrate | |
5SZS | Q6Q1S2 | Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy | |
5SZR | Q91XX7 | Protocadherin Gamma B2 extracellular cadherin domains 3-6 | |
5SZQ | Q91XY4 | Protocadherin Gamma A4 extracellular cadherin domains 3-6 | |
5SZP | Q91XX3 | Protocadherin Gamma B7 extracellular cadherin domains 1-4 P21 crystal form | |
5SZO | Q91XX3 | Protocadherin Gamma B7 extracellular cadherin domains 1-4 P41212 crystal form | |
5SZN | Q91XX9 | Protocadherin gamma A9 extracellular cadherin domains 1-5 | |
5SZM | Q91XY0 | Protocadherin gamma A8 extracellular cadherin domains 1-4 | |
5SZL | A0A0A6YW27 | Protocadherin gamma A1 extracellular cadherin domains 1-4 | |
5SZ9 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | |
5SY3 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | |
5SY2 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | |
5SXN | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | |
5SWI | A0A0Y0HIE3 | Crystal structure of SpGH92 in complex with mannose | |
5SWB | A0A0T7JX40 | Crystal structure of N-glycan transport solute binding protein (NgtS) from Streptococcus pneumoniae in complex with Man5GlcNAc | |
5SWA | A0A0T7JX40 | Crystal structure of N-glycan transport solute binding protein (NgtS) from Streptococcus pneumoniae in complex with Man1GlcNAc | |
5SVT | P56373 | Anomalous Cs+ signal reveals the site of Na+ ion entry to the channel pore of the human P2X3 ion channel through the extracellular fenestrations | |
5SVS | P56373 | Anomalous Mn2+ signal reveals a divalent cation-binding site in the head domain of the ATP-gated human P2X3 ion channel | |
5SVR | P56373 | Crystal structure of the ATP-gated human P2X3 ion channel bound to competitive antagonist A-317491 | |
5SVQ | P56373 | Crystal structure of the ATP-gated human P2X3 ion channel bound to competitive antagonist TNP-ATP | |
5SVP | P56373 | Anomalous sulfur signal reveals the position of agonist 2-methylthio-ATP bound to the ATP-gated human P2X3 ion channel in the desensitized state | |
5SVM | P56373 | Crystal structure of the ATP-gated human P2X3 ion channel bound to agonist 2-methylthio-ATP in the desensitized state | |
5SVL | P56373 | Crystal structure of the ATP-gated human P2X3 ion channel in the ATP-bound, closed (desensitized) state | |
5SVK | P56373 | Crystal structure of the ATP-gated human P2X3 ion channel in the ATP-bound, open state | |
5SVJ | P56373 | Crystal structure of the ATP-gated human P2X3 ion channel in the closed, apo state | |
5SV8 | F6I323 | Crystal Structure of the catalytic nucleophile and surface cysteine mutant of VvEG16 in complex with a xyloglucan oligosaccharide | |
5SUK | P27472 | G6P bound activated state of yeast glycogen synthase 2 | |
5SSZ | Q8NBK3 | Crystal Structure of wild-type human formylglycine generating enzyme bound to Cu(I) | |
5SSY | Q8NBK3 | Crystal Structure of human formylglycine generating enzyme | |
5SSX | Q8NBK3 | Crystal Structure human formylglycine generating enzyme E130D mutant | |
5SDT | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 15 | |
5SCL | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 1 | |
5SCK | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 42 | |
5SCJ | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 106 | |
5SCI | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 105 | |
5SCH | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 100 | |
5SCG | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 101 | |
5SCF | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 99 | |
5SCE | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 55 | |
5SCD | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 58 | |
5SCC | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 57 | |
5SCB | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 28 | |
5SCA | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 36 | |
5SC9 | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 29 | |
5SC8 | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 17 | |
5S9N | Q64610 | AUTOTAXIN, [4-(trifluoromethoxy)phenyl]methyl (3aS,6aS)-2-(1H-benzotriazole-5-carbonyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate, 1.80A, P212121, Rfree=23.3% | |
5S9M | Q64610 | AUTOTAXIN, (3,5-dichlorophenyl)methyl (3aS,8aR)-2-(1H-benzotriazole-5-carbonyl)-1,3,3a,4,5,7,8,8a-octahydropyrrolo[3,4-d]azepine-6-carboxylate, 1.80A, P212121, Rfree=21.1% | |
5S9L | Q64610 | AUTOTAXIN, 4-[3-Oxo-3-(2-oxo-2,3-dihydro-benzooxazol-6-yl)-propyl]-piperazine-1-carboxylic acid 3,5-dichloro-benzyl ester, 1.90A, P212121, Rfree=19.1% | |
5QJ3 | P05164 | CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-24 AKA 7-({4-CHLORO-3'-FLUORO-[1,1'- BIPHENYL]-3-YL}METHOXY)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN- 5-AMINE |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024